Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1

Japanese Journal of Cancer Research

Volumn 91, Issue 2, 2000, Pages 231-238

  Tomita, Yoshihiro ^a   Arakawa, Fumiko ^a   Yamamoto, Takafumi ^a   Kuwahara, Motohisa ^a   Watanabe, Ryoji ^a   Iwasaki, Hiroshi ^a   Kikuchi, Masahiro ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

FU MK 1; GA733 2; MK 1; Monoclonal antibody; Tumor associated antigen

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUNICAMYCIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL LYSATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

EID: 0034053427     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00936.x     Document Type: Article

References (36)

1. Watanabe, R., Johzaki, H., Iwasaki, H., Kikuchi, M. and Ikeda, S. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma. Cancer, 71, 2439-2447 (1993).
2. Arakawa, F., Yamamoto, T., Kanda, H., Watanabe, T. and Kuroki, M. cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse/human chimeric antibody. Hybridoma, 18, 131-138 (1999).
3. Yamamoto, T., Arakawa, F., Nakamura, K., Senba, T., Tomita, Y., Ikeda, S. and Kuroki, M. Enhanced antitumor activity of combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model. Cancer Immunol. Immunother., 48, 165-171 (1999).
4. Herlyn, M., Steplewski, Z., Herlyn, D. and Koprowski, H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 76, 1438-1442 (1979).
5. Ross, A. H., Lubeck, M., Steplewski, Z. and Koprowski, H. Identification and characterization of the CO17-1A carcinoma-associated antigen. Hybridoma, 5 (Suppl. 1), S21-S28 (1986).
6. Lipinski, M., Parks, D. R., Rouse, R. V. and Herzenberg, L. A. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc. Nati. Acad. Sci. USA, 78, 5147-5150 (1981).
7. Alberti, S., Nutini, M. and Herzenberg, L. A. DNA methylation prevents the amplification of TROPl, a tumor-associated cell surface antigen gene. Proc. Natl. Acad. Sci. USA, 91, 5833-5837 (1994).
8. Varki, N. M., Reisfeld, R. A. and Walker, L. E. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res., 44, 681-687 (1984).
9. Strnad, J., Hamilton, A. E., Beavers, L. S., Gamboa, G. C., Apelgren, L. D., Taber, L. D., Sportsman, J. R., Bumol, T. F., Sharp, J. D. and Gadski, R. A. Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res., 49, 314-317 (1989).
10. Perez, M. S. and Walker, L. E. Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker. J. Immunol., 142, 3662-3667 (1989).
11. Herlyn, D., Herlyn, M., Ross, A. H., Ernst, C., Atkinson, B. and Koprowski, H. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J. Immunol. Methods, 73, 157-167 (1984).
12. Szala, S., Froehlich, M., Scollon, M., Kasai, Y., Steplewski, Z., Koprowski, H. and Linnenbach, A. J. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc. Natl. Acad. Sci. USA, 87, 3542-3546 (1990).
13. Momburg, F., Moldenhauer, G., Hämmerling, G. J. and Möller, P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res., 47, 2883-2891 (1987).
14. Simon, B., Podolsky, D. K., Moldenhauer, G., Isselbacher, K. J., Gattoni-Celli, S. and Brand, S. J. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc. Natl. Acad. Sci. USA, 87, 2755-2759 (1990).
15. Larson, L. N., Johansson, C., Lindholm, L. and Holmgren, J. Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells. Int. J. Cancer, 42, 877-882 (1988).
16. Björk, P., Jönsson, U., Svedberg, H., Larsson, K., Lind, P., Dillner, J., Hedlund, G., Dohlsten, M. and Kalland, T. Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J. Biol. Chem., 268, 24232-24241 (1993).
17. de Leij, L., Helrich, W., Stein, R. and Mattes, M. J. SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int. J. Cancer, Suppl. 8, 60-63 (1994).
18. Stahel, R. A., Gilks, W. R., Lehmann, H.-P. and Schenker, T. Third international workshop on lung tumor and differentiation antigens: overview of the results of the central data analysis. Int. J. Cancer, Suppl. 8, 6-26 (1994).
19. Shetye, J., Frödin, J.-E., Christensson, B., Grant, C., Jacobsson, B., Sundelius, S., Sylvén, M., Biberfeld, P. and Mellstedt, H. Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunol. Immunother., 27, 154-162 (1988).
20. Elias, D. J., Hirschowitz, L., Kline, L. E., Kroener, J. F., Dillman, R. O., Walker, L. E., Robb, J. A. and Timms, R. M. Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunoconjugate in patients with non-small cell lung carcinoma. Cancer Res., 50, 4154-4159 (1990).
21. Herlyn, D., Sears, H. F., Ernst, C. S., Iliopoulos, D., Steplewski, Z. and Koprowski, H. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma. Am. J. Clin. Oncol., 14, 371-378 (1991).
22. LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J. and Khazaeli, M. B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. USA, 86, 4220-4224 (1989).
23. Trang, J. M., LoBuglio, A. F., Wheeler, R. H., Harvey, E. B., Sun, L., Ghrayeb, J. and Khazaeli, M. B. Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients. Pharm. Res., 7, 587-592 (1990).
24. Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Pichlmaier, H., Hirche, H., Pichlmayr, R., Buggisch, P., Witte, J. and the German Cancer Aid 17-1A Study Group. Randomised trial of monoclonal antibody for adjuvant therapy of resected Duke's C colorectal carcinoma. Lancet, 343, 1177-1183 (1994).
25. Fagerberg, J., Hjelm, A.-L., Ragnhammar, P., Frödin, J.-E., Wigzell, H. and Mellstedt, H. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes. Cancer Res., 55, 1824-1827 (1995).
26. Göttlinger, H. G., Funke, I., Johnson, J. P., Gokel, J. M. and Riethmüller, G. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer, 38, 47-53 (1986).
27. K genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody. J. Biochem., 120, 657-662 (1996).
28. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
29. Hama-Inaba, H., Takahashi, M., Kasai, M., Shiomi, T., Ito, A., Hanaoka, F. and Sato, K. Optimum conditions for electric pulse-mediated gene transfer to mammalian cells in suspension. Cell Struct. Funct., 12, 173-180 (1987).
30. Bonner, W. M. and Laskey, R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem., 46, 83-88 (1974).
31. Schön, M. P., Schön, M., Mattes, M. J., Stein, R., Weber, L., Alberti, S. and Klein, C. E. Biochemical and immunological characterization of the human carcinoma-associated antigen MH 99/KS 1/4. Int. J. Cancer, 55, 988-995 (1993).
32. Mattes, M. J., Lloyd, K. O. and Lewis, J. L., Jr. Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells. Cancer Immunol. Immunother., 28, 199-207 (1989).
33. Stein, R., Chen, S., Sharkey, R. M. and Goldenberg, D. M. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting. Cancer Res., 50, 1330-1336 (1990).
34. Mattes, M. J., Look, K., Furukawa, K., Pierce, V. K., Old, L. J., Lewis, J. L., Jr. and Lloyd, K. O. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res., 47, 6741-6750 (1987).
35. Spurr, N. K., Durbin, H., Sheer, D., Parkar, M., Bobrow, L. and Bodmer, W. F. Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI. Int. J. Cancer, 38, 631-636 (1986).
36. Caton, A. J. Comparative sequence analysis of CO17-1A antigen-specific monoclonal antibodies. Hybridoma, 5 (Suppl. 1), S11-S16 (1986).